GSK application for expanded indication of Jemperli plus chemotherapy accepted by USFDA for priority review Ruchika Sharma25 April 2024 12:40 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
USFDA accepts for review GSK 5-in-1 meningococcal ABCWY vaccine candidate Ruchika Sharma17 April 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
WHO issues warning for growing resistance to HIV drug of GSK Roshni Dhar11 March 2024 5:58 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Health Bulletin 11/ March/ 2024 Roshni Dhar11 March 2024 4:58 PM ISTHere are the top health news for the day:NEET UG 2024 registration deadline extendedThe deadline for NEET 2024 application submissions has been...
WHO warns of growing resistance to GSK HIV drug Ruchika Sharma6 March 2024 12:30 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
GSK CEO Emma Walmsley total remuneration rises 51 percent to USD 16 million in 2023 Ruchika Sharma4 March 2024 10:00 AM ISTLondon: GSK CEO Emma Walmsley's total remuneration rose 51 per cent to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in...
Heartburn drug: GSK settles another lawsuit on Zantac in California Ruchika Sharma3 March 2024 2:00 PM ISTThe USFDA in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.
GSK posts positive headline results from phase III trial for Gepotidacin in uncomplicated urogenital gonorrhoea Ruchika Sharma27 Feb 2024 2:30 PM ISTGSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic...
GSK gets USFDA Fast Track designation for Bepirovirsen in chronic hepatitis B Ruchika Sharma12 Feb 2024 3:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an...
USFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine Ruchika Sharma8 Feb 2024 4:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted under priority review an application to extend the...
GSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for review in China Ruchika Sharma8 Feb 2024 1:30 PM ISTLondon: GSK plc has announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted...
GSK vaccine Arexvy accepted for regulatory review by EMA for adults aged 50-59 at increased risk for RSV Ruchika Sharma4 Feb 2024 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use of its...
